News | Radiation Dose Management | March 06, 2019

Associations remind general public that danger from irradiated remains is minimal

AAPM and ACR Address JAMA Article on Radioactive Material in Cremated Bodies

March 6, 2019 — A recent Journal of the American Medical Association (JAMA) publication1 describing the cremation of patient remains containing a radioactive material garnered considerable media attention and may have alarmed some members of the general public.

The American Association of Physicists in Medicine (AAPM) and the American College of Radiology (ACR) released a series of key points to put the topic into better perspective.

The associations want the general public to know:  

  • Radioactive materials are used routinely in medical practice to improve human health;

  • The risk of harm to the crematorium operator is so small that it cannot be measured;

  • Consensus guidelines from national (CDC and DOE) international radiation protection and public health organizations provide clear guidance on how to identify radioactivity in patient remains and appropriately deal with the body of the decedent;  

  • Healthcare providers who administer radioactive material must have a designated Radiation Safety Officer whose credentials meet criteria established by the U.S. Nuclear Regulatory Commission (A and B), the federal agency that regulates the use of radioactive materials. These individuals are often certified medical physicists or health physicists; and

  • The low-cost best practice of installing a simple radiation detector in hospital morgues, funeral homes and crematoriums would quickly alert staff to the presence of radioactivity. A certified medical physicist or health physicist has the expertise to determine when the measured radiation levels will have decreased to a level where it is safe to release the body to coroners, medical examiners or mortuary services.

For more information:,


1. Yu N.Y., Rule W.G., Sio T.T., et al. Radiation Contamination Following Cremation of a Deceased Patient Treated with a Radiopharmaceutical. JAMA. 2019;321(8):803-804.

Related Content

News | Proton Therapy

October 22, 2021 — RaySearch Laboratories AB and Mevion Medical Systems, two companies that are leading the field of ...

Time October 22, 2021
Webinar | Radiation Dose Management

A holistic view of contrast and radiation dose data is imperative to help identify opportunities for clinical and ...

Time August 27, 2021
News | Radiation Dose Management

August 17, 2021 — Expert medical organizations caution that evidence-based ordering of medically necessary imaging exams ...

Time August 17, 2021
News | Computed Tomography (CT)

July 9, 2021—According to ARRS’ American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than 90% of ...

Time July 09, 2021
Feature | Computed Tomography (CT) | By Mikael Strindlund

Computed tomography (CT) imaging has broad diagnostic application and is the imaging gold standard for many clinical ...

Time July 02, 2021
News | Lung Imaging

April 30, 2021 — For many patients with localized lung cancer (non-small-cell lung carcinoma and small cell lung ...

Time April 30, 2021
Feature | Radiation Dose Management | By Dave Fornell

More than a decade ago, there was an alarming, rapid rise in ionizing radiation exposure in the U.S. population that was ...

Time March 04, 2021
News | Radiation Dose Management

February 5, 2021 — Real Time Imaging Technologies LLC has received U.S. Patent No. 10,898,070 IMAGING APPARATUS AND ...

Time February 05, 2021
News | Radiation Dose Management

December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose ...

Time December 11, 2020
News | Radiation Dose Management

August 3, 2020 — According to the new market research report "Radiation Dose Management Market by Products & Services ...

Time August 03, 2020
Subscribe Now